FDA clears Optovue’s epi-mapping software

18:00 EDT 9 Aug 2017 | Healio

Optovue’s epithelial thickness mapping software has become the first to be cleared by the FDA for quantitative measurements of the epithelial and stromal layers of the cornea, according to a company press release. Aiding in the diagnosis, documentation and management of ocular health and diseases, epi-mapping provides epithelial thickness information in a fast, non-contact exam, the release said. It is available through the iVue and iFusion OCT systems.

Original Article: FDA clears Optovue’s epi-mapping software


More From BioPortfolio on "FDA clears Optovue’s epi-mapping software"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...